Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories


Stryker gathers OrthoSpace in $220m deal
Smith & Nephew and Johnson & Johnson have exited the shoulder implant developer in an all-cash acquisition by Stryker that could reach $220m.
Alcon sees way to $285m PowerVision acquisition
Alcon acquired the intraocular lens developer in a $285m deal that follows $106m in funding from investors including its parent company Novartis as well as Johnson & Johnson and Medtronic.
Imara imports $63m in series B funding
The sickle cell disease therapy developer boosted its overall funding to $94m in a round backed by Lundbeck, Pfizer and Alexandria Real Estate Equities.
Karuna collects $68m in series B round
The central nervous system disorder drug developer has now raised more than $118m, with PureTech Health and Pivotal BioVenture Partners among the investors in its latest round.
Artemis Health arcs to $25m series C
Hearst Health Ventures contributed to a BVP-led round that boosted the health benefits data platform's total funding to about $51m.
Corporate venturing deal net: 11-15 March 2019
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
TriNetX triumphs in $40m series D
The healthcare research platform has increased its total funding to $102m following a Merck GHI-led round that included Itochu Technology Ventures and Mitsui.
Aldrich administers $41m to eHealth
The medical record retrieval software provider, which received funding from Merck & Co in 2013, has secured $41m from Aldrich Capital Partners.

Other News

Docquity rocks $11m series B round
The physician-based social media platform has raised $11m in a round co-led by Itochu, which supplied $6m, and existing backer Singapore Press Holdings.
Verano to reap $850m in Harvest acquisition
Scythian Biosciences-backed cannabis facilities operator Verano has agreed to an $850m acquisition by Harvest Health and Recreation in an all-stock transaction.
InventisBio invites Eli Lilly to $70m series C
Lilly Asia Ventures has returned for a series C round that boosted the total raised by the cancer and metabolic disease drug developer to $100m.
Snipr hits funding target to raise $50m
Founding investor Lundbeckfonden Emerge returned to co-lead a series A round for the gene editing drug developer with Life Science Partners.
Oscor goes to MID for $20m series D
Medical device producer Oscor has led the heart disease treatment system developer's $20m series D round in connection with a strategic partnership.
Shockwave makes stock market impact
Abiomed-backed Shockwave Medical has raised approximately $97m in an oversubscribed initial public offering, before its shares climbed more than 85% by the end of Friday.

Editor's Picks

M&A of the Year: Prexton Therapeutics
Having emerged from the Merck Serono Entrepreneur Partnership Program (EPP) in 2015, Prexton Therapeutics raised a total $41m of funding before it was acquired by pharmaceutical firm Lundbeck for an estimated $1.1bn last year.
CVC in 2018 - The Trends: Part Two
In the second half of our guide to corporate venturing's biggest trends in 2018, we look at the growth of Chinese tech companies, genomics, advances in transport tech and the growth of the scooter rental space.
Relay Therapeutics runs away with $400m
SoftBank Vision Fund led a series B round for the cancer therapy developer that was also backed by GV and Alexandria Venture Investments.
Zymergen climbs to $400m series C
The molecular product technology provider followed a nine-figure, SoftBank-led round two years ago with a series C led by the corporate's Vision Fund.
test reg